ATS 2018 International Conference - Mobile

Harrison W. Farber

MD

Boston Univ Sch of Med;Boston University School of Medicine;Pulmonary Center, Boston University School of Medicine

Session(s)

Comparison of Three Risk Assessment Strategies as Predictors of One-Year Survival in US Pu...
Sunday, May 20 9:15 AM - 11:15 AM
Obesity Is Associated with Better Hemodynamic Measurements in Patients with Sarcoidosis As...
Sunday, May 20 11:15 AM - 1:00 PM
Riociguat in Pulmonary Arterial Hypertension (PAH): Evaluation of Abbreviated Versions of ...
Sunday, May 20 11:15 AM - 1:00 PM
The United States Pulmonary Hypertension Scientific Registry (USPHSR): Preliminary Genomic...
Sunday, May 20 11:15 AM - 1:00 PM
Morphing Physiology: A Case of Occult Systemic Sclerosis Sine Scleroderma Associated Pulmo...
Monday, May 21 11:15 AM - 1:00 PM
Riociguat in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Evaluation of Abbrevia...
Monday, May 21 11:15 AM - 1:00 PM
Baseline and Demographic Data on the First 250 Patients from SPHERE (Uptravi® [SelexiPag]:...
Tuesday, May 22 11:15 AM - 1:00 PM
Outcomes of Patients with Pulmonary Hypertension Associated with Sarcoidosis Treated with ...
Tuesday, May 22 11:15 AM - 1:00 PM
Prevalence and Associated Mortality of an Echocardiographic Diagnosis of Pulmonary Hyperte...
Tuesday, May 22 11:15 AM - 1:00 PM
Transitions from Inhaled, Intravenous, Subcutaneous, or Oral Prostacyclins to Selexipag: I...
Tuesday, May 22 11:15 AM - 1:00 PM
A High Pressure Situation: Pulmonary Arterial Hypertension and a Large Pericardial Effusio...
Wednesday, May 23 11:15 AM - 1:00 PM
Ralinepag Plasma Levels Correlate with Improvements in Functional and Hemodynamic Paramete...
Wednesday, May 23 1:30 PM - 3:30 PM
Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertens...
Wednesday, May 23 1:30 PM - 3:30 PM